ResMed's (ASX:RMD) Chief Financial Officer Brett Sandercock sold 1,000 common shares on the New York Stock Exchange for $215,580 in total, according to a Wednesday filing with the Australian bourse.
Following the sale of shares, Sandercock owns about 146.9 million shares in the company, per the filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.